Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.12% Nasdaq Down0.18%

Nektar Therapeutics (NKTR)

-NasdaqGS

10.55 Up 0.74(7.54%) 12:45PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 23,004   21,146   18,412   23,684  
Cost of Revenue11,661  7,290  7,228  7,203  
Gross Profit 11,343   13,856   11,184   16,481  
Operating Expenses
Research Development45,618  46,373  34,016  33,201  
Selling General and Administrative11,129  10,864  10,068  10,268  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (45,404) (43,381) (32,900) (26,988)
Income from Continuing Operations
Total Other Income/Expenses Net741  520  759  727  
Earnings Before Interest And Taxes(44,663)(42,861)(32,141)(26,261)
Interest Expense10,188  10,098  11,184  7,931  
Income Before Tax(54,851)(52,959)(43,325)(34,192)
Income Tax Expense212  (33)222  93  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(55,063)(52,926)(43,547)(34,285)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (55,063) (52,926) (43,547) (34,285)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (55,063) (52,926) (43,547) (34,285)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.